← Back to Search

Behavioral Intervention

Online Intervention for HIV/AIDS (ORCHID-Miami Trial)

Q: Who is able to access the benefits of participating in this clinical experiment?

<p>Candidates who are <a href="https://www.withpower.com/clinical-trials/hiv">HIV</a>/<a href="https://www.withpower.com/clinical-trials/aids">AIDS</a> positive and aged between 18 to 90 years old may be accepted into this trial. In total, 30 individuals have the opportunity of being enrolled in it.</p>

N/A

Waitlist Available

Led By Lunthita M Duthely, Ed.D.

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months

Awards & highlights

ORCHID-Miami Trial Summary

This trial tests a skills-building intervention to help HIV+ people stay in care & improve their mental health.

Who is the study for?

The ORCHID trial is for adult women with HIV who are treated at the University of Miami Women's HIV Service. They must have had HPV or related health issues in the past year and may struggle with substance use or mental health conditions like depression, anxiety, or PTSD. Participants should not be cognitively impaired, imprisoned, under 18, unable to read/write English at a basic level, or have severe psychiatric disorders.Check my eligibility

What is being tested?

ORCHID is an online program designed to help improve mental well-being in women living with HIV. It focuses on building skills to cope better and stay engaged in their healthcare. The study will evaluate how effective this intervention is for those who might be at risk of dropping out of care due to various challenges.See study design

What are the potential side effects?

Since ORCHID is a non-medical online intervention focusing on resilience and coping strategies rather than medication or physical treatments, it does not have traditional side effects associated with drugs or medical procedures.

ORCHID-Miami Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of Participants who Complete ORCHID

Secondary outcome measures

Depression as measured by Patient Health Questionnaire (PHQ-9)

Positive Affect as measured by Positive and Negative Affect Schedule (PANAS)

ORCHID-Miami Trial Design

1Treatment groups

Experimental Treatment

Group I: ORCHID GroupExperimental Treatment1 Intervention

Participants in the ORCHID group will receive an online intervention that improves depressive symptoms and positive affect (emotions) for clinic-based persons living with HIV, for up to 6 months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor

898 Previous Clinical Trials

409,621 Total Patients Enrolled

Northwestern UniversityOTHER

1,585 Previous Clinical Trials

917,201 Total Patients Enrolled

Lunthita M Duthely, Ed.D.Principal InvestigatorUniversity of Miami

1 Previous Clinical Trials

75 Total Patients Enrolled

Media Library

ORCHID (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05935644 — N/A

HIV/AIDS Research Study Groups: ORCHID Group

HIV/AIDS Clinical Trial 2023: ORCHID Highlights & Side Effects. Trial Name: NCT05935644 — N/A

ORCHID (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05935644 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is able to access the benefits of participating in this clinical experiment?

"Candidates who are HIV/AIDS positive and aged between 18 to 90 years old may be accepted into this trial. In total, 30 individuals have the opportunity of being enrolled in it."

Answered by AI

Is the enrollment process still open for this scientific investigation?

"Information hosted on clinicaltrials.gov reveals that, as of June 29th 2023, this specific trial is not enrolling patients. Although it was initially posted in September 1st 2023, there are currently 195 other studies actively seeking participants."

Answered by AI

Is the minimum age for this clinical research 18 years or younger?

"This clinical study is open to participants between 18 and 90 years of age. Conversely, there are 45 trials tailored for those under the legal age of consent, as well as 115 specifically designed for seniors over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ORCHID: An Online Intervention for Persons With HIV (Miami)

Lunthita M. Duthely 2024. "ORCHID: An Online Intervention for Persons With HIV (Miami)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05935644.

All > Hpv